Global Occupational Respiratory Disorders Market – Industry Trends and Forecast to 2030

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Occupational Respiratory Disorders Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Occupational Respiratory Disorders Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 9,308.01 Million
Diagram Market Size (Forecast Year)
USD 15,174.80 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Occupational Respiratory Disorders Market, By Disease Type (Asbestosis, Black Lung Disease, Silicosis, Byssinosis, Hypersensitivity Pneumonitis, Work-Related Asthma and Others), Cause (Organic and Inorganic), Drugs Type (Mycolytics, Antibiotics, Corticosteroids, Antihistmains and Others), Severity (Acute and Chronic), Route of Administration (Oral, Nasal, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers, Research Institute, and, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.

 Occupational Respiratory Disorders Market

Occupational Respiratory Disorders Market Analysis and Size

An increase in the prevalence of occupational respiratory disorders, increasing smoking population, and rising air pollution will assist in encouraging the growth of the market. However, strict pricing and reimbursement policies, high cost of drugs, will restraint the occupational respiratory disorders market.               

Data Bridge Market Research analyses that the global occupational respiratory disorders market, which was USD 9,308.01 million in 2022, is expected to reach USD 15,174.80 million by 2030, and is expected to undergo a CAGR of 6.30% during the forecast period 2023-2030. This indicates that the asbestosis segment dominates the disease type segment of the global occupational respiratory disorders market owing to the advancements in technology that have led to the development of rapid and implant drugs and treatments for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Occupational Respiratory Disorders Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Disease Type (Asbestosis, Black Lung Disease, Silicosis, Byssinosis, Hypersensitivity Pneumonitis, Work-Related Asthma and Others), Cause (Organic and Inorganic), Drugs Type (Mycolytics, Antibiotics, Corticosteriods, Antihistmains and Others), Severity (Acute and Chronic), Route of Administration (Oral, Nasal, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers, Research Institute, and, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

GlaxoSmithKline Plc (U.K.), AstraZeneca (U.K.),  Novartis AG (Switzerland),Johnson & Johnson (U.S.), Mylan N.V, ( U.S.),  Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Limited (Israel), Gilead Sciences, Inc ( U.S.),  Bayer AG (Germany), Pfizer Inc. ( U.S.), Bristol-Myers Squibb ( U.S.), Merck & Co. ( U.S.),  Sanofi (France), Mallinckrodt plc(U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Inc ( U.S.)

Market Opportunities

  • Growing Healthcare Expenditure
  • Technological Advancement

Market Definition

Occupational respiratory disorders, also known as work-related respiratory diseases, are a group of conditions that are caused or exacerbated by exposure to hazardous substances or conditions in the workplace. These disorders affect the respiratory system, including the lungs, airways, and related structures.

Global Occupational Respiratory Disorders Market Dynamics

Drivers

  • Increasing Awareness

There has been a growing awareness among workers and employers about the risks associated with occupational respiratory disorders. This has led to an increased demand for preventive measures and early diagnosis of respiratory disorders, driving the market growth.

  • Increasing Industrialization

The rapid industrialization in emerging economies has resulted in a higher number of workers being exposed to occupational respiratory hazards. This has created a greater demand for respiratory protective equipment and monitoring devices, driving the market growth.

  • Occupational Health and Safety Initiatives

Several organizations and companies have started implementing comprehensive occupational health and safety programs to protect their workforce from respiratory hazards. This includes regular health check-ups, training on the proper use of respiratory protective equipment, and monitoring of workplace air quality. These initiatives have contributed to the growth of the market.

Opportunities

  • Technological Advancements

The development of advanced respiratory monitoring devices, such as portable spirometers, wearable devices, and real-time air quality monitoring systems, has significantly contributed to the growth of the market. These devices offer accurate and real-time monitoring of respiratory parameters, aiding in early diagnosis and treatment of respiratory disorders.

  • Growing Healthcare Expenditure

The increasing healthcare expenditure globally has led to improved access to healthcare facilities and diagnostic services. This has positively impacted the demand for diagnostic tests and treatment options for occupational respiratory disorders, driving the market growth.

Restraints/Challenges

  • Workplace Monitoring and Measurement Equipment

This segment includes the development and sale of monitoring and measurement equipment that assesses air quality, particulate matter levels, and exposure to harmful substances. Innovations in real-time monitoring are driving growth in this area.

  • Regulatory Compliance Solutions

Companies often invest in software and solutions that help them navigate and comply with occupational health and safety regulations related to respiratory hazards. These solutions assist in managing compliance records and safety data.

The global occupational respiratory disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global occupational respiratory disorders market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In September 2021, 3M announced the launch of their new Powered Air Purifying Respirator (PAPR) system called Versaflo TR-600. This system is designed to provide respiratory protection for workers in various industries, including those at risk of occupational respiratory disorders
  • In July 2021, Honeywell announced the expansion of their respiratory protection product line with the introduction of the North 7700 Series Half Mask. This mask is designed to provide a comfortable and secure fit, helping to protect workers from airborne contaminants in occupational settings

Global Occupational Respiratory Disorders Market Scope

The global occupational respiratory disorders market is segmented on the basis of disease type, cause, drugs type, severity, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type  

  • Asbestosis
  • Black Lung Disease
  •  Silicosis
  •  Byssinosis
  •  Hypersensitivity Pneumonitis
  • Work-Related Asthmaa
  • Others

Cause

  • Organic
  • Inorganic

Drugs Type

  • Mycolytics
  • Antibiotics
  • Corticosteriods
  •  Antihistmains
  • Others

Severity

  • Acute
  • Chronic

Route of Administration

  •  Oral
  • Nasal
  • Parenteral

End User

  • Hospitals
  •  Specialty Clinics
  •  Diagnostic Centers
  •  Research Institute
  •  Others

Distribution Channel

  • Hospital Pharmacy
  •  Retail Pharmacy
  • Online Pharmacies
  • Others

Global Occupational Respiratory Disorders Market Analysis/Insights

The global occupational respiratory disorders market is analyzed and market size insights and trends are provided by country, disease type, cause, drugs type, severity, route of administration, end user, and distribution channel as referenced above.

The countries covered in the global occupational respiratory disorders market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global occupational respiratory disorders market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the occupational respiratory disorders products, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Occupational Respiratory Disorders Market Share Analysis

The global occupational respiratory disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global occupational respiratory disorders market.

Some of the major players operating in the global occupational respiratory disorders market are:

  • GlaxoSmithKline Plc (U.K.)
  • AstraZeneca (U.K.)
  • Novartis AG (Switzerland)
  • Johnson & Johnson (U.S.)
  • Mylan N.V, (U.S.)
  • Boehringer Ingelheim GmbH (Germany)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Gilead Sciences, Inc (U.S.)
  • Bayer AG: Leverkusen, Germany
  • Pfizer Inc. (U.S.)
  • Bristol-Myers Squibb (U.S.)
  • Merck & Co. (U.S.)
  • Sanofi (France)
  • Mallinckrodt plc(U.K.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Vertex Pharmaceuticals Inc (U.S.) 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The occupational respiratory disorders market size will be worth USD 15,174.80 million by 2030
The growth rate of the occupational respiratory disorders market is 6.30% in the forecast period by 2030.
Growing awareness among workers and employers about the risks associated with occupational respiratory disorders & comprehensive occupational health and safety programs are the growth drivers of the occupational respiratory disorders market.
Disease type, cause, drugs type, severity, route of administration, end user, and distribution channel are the factors on which the occupational respiratory disorders market research is based.
Major companies in the occupational respiratory disorders market are GlaxoSmithKline Plc (U.K.), AstraZeneca (U.K.), Novartis AG (Switzerland),Johnson & Johnson (U.S.), Mylan N.V, ( U.S.), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Limited (Israel), Gilead Sciences, Inc ( U.S.), Bayer AG (Germany), Pfizer Inc. ( U.S.), Bristol-Myers Squibb ( U.S.), Merck & Co. ( U.S.), Sanofi (France), Mallinckrodt plc(U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Inc ( U.S.)